Company / Cash per Share
Benitec Biopharma Inc. Cash per Share History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$8.84
FY2021
5-year range
$8.84 / $18.35
FY2020-FY2021
Trend
-51.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
8.84 in FY2021.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, cash per share decreased 51.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.32 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $8.84 | -51.8% |
| FY2020 | $18.35 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026